Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Times Interest Earned: 2010-2022

Historic Times Interest Earned for Niagen Bioscience (NAGE) over the last 9 years, with Sep 2022 value amounting to -$613.

  • Niagen Bioscience's Times Interest Earned fell 4.00% to -$613 in Q3 2022 from the same period last year, while for Sep 2022 it was -$703.12, marking a year-over-year decrease of 56.60%. This contributed to the annual value of -$492.24 for FY2021, which is 76.03% down from last year.
  • Niagen Bioscience's Times Interest Earned amounted to -$613 in Q3 2022, which was up 4.02% from -$638.70 recorded in Q2 2022.
  • In the past 5 years, Niagen Bioscience's Times Interest Earned registered a high of $1,266 during Q4 2019, and its lowest value of -$966.50 during Q1 2022.
  • For the 3-year period, Niagen Bioscience's Times Interest Earned averaged around -$515.67, with its median value being -$526.12 (2021).
  • Within the past 5 years, the most significant YoY rise in Niagen Bioscience's Times Interest Earned was 287.75% (2018), while the steepest drop was 1,253.27% (2018).
  • Niagen Bioscience's Times Interest Earned (Quarterly) stood at $374.55 in 2018, then spiked by 237.93% to $1,266 in 2019, then crashed by 130.03% to -$380.06 in 2020, then crashed by 55.41% to -$590.67 in 2021, then dropped by 4.00% to -$613 in 2022.
  • Its Times Interest Earned stands at -$613 for Q3 2022, versus -$638.70 for Q2 2022 and -$966.50 for Q1 2022.